on Kexing Biopharm
Kexing Biopharm Explores Global Expansion at CPHI Frankfurt 2025
From October 28th to 30th, Kexing Biopharm participated in CPHI Frankfurt 2025, a major pharmaceutical exhibition. The company highlighted its product portfolio and global commercialization strategies to a diverse international audience.
During the event, Kexing’s team engaged in discussions regarding product registration and market access, emphasizing localized collaboration. The company showcased its full-cycle pharmaceutical capabilities, supported by compliant quality and regulatory systems.
Kexing actively interacted with industry peers, gathering insights on market trends and policies. This experience will inform the company's strategy for further overseas expansion and potential client identification.
With a focus on international growth, Kexing continues to prioritize innovation in healthcare solutions, aiming to enhance global accessibility to quality medicine.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Kexing Biopharm news